(Q64794904)
Statements
OPTIPRIME (English)
0 references
A Phase II Study Evaluating FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation (English)
0 references
26 April 2018
0 references
April 2020
0 references
118
0 references
18 year
0 references